Valuation: Seegene, Inc.

Market Cap 1,319B 851M 747M 687M 641M 1.21B 80.86B 1.23B 8.27B 3.2B 39.69B 3.19B 3.12B 138B P/E 2026 *
16.3x
P/E 2027 * 13.8x
Enterprise Value 1,319B 851M 747M 687M 641M 1.21B 80.86B 1.23B 8.27B 3.2B 39.69B 3.19B 3.12B 138B EV / Sales 2026 *
2.48x
EV / Sales 2027 * 2.19x
Free-Float
59.55%
Yield 2026 *
3.83%
Yield 2027 * 4.15%
1 day-3.37%
1 week+6.49%
Current month-3.37%
1 month-6.06%
3 months+25.05%
6 months+20.59%
Current year+20.59%
1 week 27,600
Extreme 27600
31,450
1 month 26,350
Extreme 26350
32,000
Current year 21,700
Extreme 21700
32,500
1 year 21,700
Extreme 21700
33,350
3 years 19,040
Extreme 19040
36,650
5 years 19,040
Extreme 19040
94,700
10 years 7,225
Extreme 7225
161,100
Manager TitleAgeSince
Chief Executive Officer 69 2010-09-16
President 54 -
President 74 -
Director TitleAgeSince
Director/Board Member 69 2011-06-30
Chairman 79 -
Director/Board Member 74 -
Date Insider Type Main position Quantity % Market Cap.
24-05-29Sell

Executive/Senior Manager

191 0.0004%
24-05-29Sell

Executive/Senior Manager

4,201 0.0080%
Change 5-day change 1-year change 3-year change Capi.($)
-3.37%+6.49%-12.37%+39.66% 854M
-2.31%-0.44%+111.37%+133.93% 4.78B
-2.75%+7.65%+89.90%+226.35% 3.58B
+5.11%+3.45%-26.18%-38.57% 2.08B
-0.13%-5.58%+127.14%-44.01% 1.77B
-2.99%+2.23%+46.07%+235.34% 1.51B
-0.33%+1.14%+133.58%-50.24% 907M
-3.83%+1.31%+12.59% - 516M
+3.53%-0.02%-36.78%-18.54% 484M
+3.54%-0.51% - - 208M
Average -0.27%+4.23%+49.48%+60.49% 1.67B
Weighted average by Cap. -0.91%+5.80%+72.41%+101.87%

Financials

2026 *2027 *
Net sales 531B 342M 301M 277M 258M 486M 32.55B 496M 3.33B 1.29B 15.98B 1.29B 1.26B 55.6B 603B 389M 342M 314M 293M 553M 36.99B 564M 3.78B 1.47B 18.16B 1.46B 1.43B 63.19B
Net income 92.2B 59.46M 52.21M 48.05M 44.78M 84.45M 5.65B 86.16M 578M 224M 2.77B 223M 218M 9.66B 108B 69.84M 61.32M 56.44M 52.6M 99.19M 6.64B 101M 679M 263M 3.26B 262M 257M 11.34B
Net Debt - -
Logo Seegene, Inc.
Seegene Inc is a Korea-based company engaged in the development, manufacturing and distribution of molecular diagnostic reagents. The Company mainly provides infectious pathogens inspection products, including allergic respiratory pathogens, sexually transmitted diseases pathogens, human papilloma virus (HPV) and other inspection products, drug resistance inspection products, single nucleotide polymorphisms (SNP) inspection products, as well as somatic mutation cancer inspection products. In addition, it is involved in the provision of automatic real-time detection instruments. The Company provides its products under the brand names of Seeplex, Anyplex and Magicplex. The Company distributes its products within domestic market and to overseas markets.
Employees
216
Date Price Change Volume
26-07-02 ₩28,950.00 +0.87% 166,162
26-07-01 ₩28,700.00 -3.37% 256,647
26-06-30 ₩29,700.00 -2.46% 217,379
26-06-29 ₩30,450.00 +8.75% 399,845
26-06-26 ₩28,000.00 -3.95% 331,602
Trader
Investor
Global
Quality
ESG MSCI
CCC
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
28,700.00KRW
Average target price
39,500.00KRW
Spread / Average Target
+37.63%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A096530 Stock